CtrlK
HUM
NYSE
Health Care
$407.78
USD
+$1.01 (+0.25%)
At close: Jul 15, 2026, 4:00 PM EDT
Market Cap:
$49.08B
Volume:
1.6M
Previous Close
$406.77
Day Range
$394.46 - $412.33
52 Week Range
$163.11 - $415.00
Average Volume (10 Days)
1.3M
P/E Ratio
41.31
Dividend Yield
0.87%
Humana Inc. engages in the provision of health insurance services. The company is headquartered in Louisville, Kentucky and currently employs 67,060 full-time employees. The firm's segments include Insurance and CenterWell. The Insurance segment consists of Medicare benefits, marketed to individuals or directly via group Medicare accounts, as well as its contract with CMS to administer the Limited Income Newly Eligible Transition (LI-NET) prescription drug plan program and contracts with various states to provide Medicaid, dual eligible demonstration, and Long-Term Support Services benefits. This segment also includes products consisting of employer group commercial fully-insured medical and specialty health insurance benefits marketed to individuals and employer groups. The CenterWell segment includes its pharmacy, primary care, and home solutions operations. The segment also includes its strategic partnerships with WCAS to develop and operate senior-focused, payor-agnostic, primary care centers, as well as its minority ownership interest in hospice operations.
CEO
Mr. James Rechtin
Headquaters
Louisville, KENTUCKY, US
Founded
1971
Employees
67,060
Arizona's Attorney General filed an antitrust lawsuit accusing MultiPlan (now Claritev) and major insurers including Aetna, Cigna, and UnitedHealthcare of using a shared pricing algorithm to systematically underpay out-of-network medical claims. The lawsuit alleges this scheme forced providers to accept below-cost payments while increasing patients' out-of-pocket costs, with one hospital system claiming tens of millions in underpayments.
0
0
UnitedHealthcare announced it will eliminate prior authorization requirements for 30% of services that currently need insurer approval, affecting approximately 50 million members. The changes, set to take effect by the end of 2026, include select outpatient surgeries, diagnostic tests like echocardiograms, and certain therapies—representing the largest single reduction by any major insurer in recent years.
0
0
Humana delivered strong first-quarter earnings and better-than-expected medical cost control, but chose not to raise its full-year profit outlook. The company maintained its adjusted profit forecast at a minimum of $9 per share, citing persistent funding gaps between government payments and medical costs. The company signaled it will adjust benefits in 2027 to meet long-term margin targets.
0
0
